Health
Pharma’s Tariff Reprieve Will Be Temporary as More Levies Loom
This article is for subscribers only.
Supply Lines is a daily newsletter that tracks global trade. Sign up here.
The drug industry won a reprieve from sweeping tariffs announced by President Donald Trump on Wednesday, though it could be short-lived as the White House moves forward with plans for future levies on pharmaceutical imports.